Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Falsely high urinary catecholamines induced by labetalol

K Kobayashi, Y Miura, H Tomioka

    The Tohoku Journal of Experimental Medicine
    |January 1, 1979
    PubMed
    Summary

    Labetalol treatment can falsely elevate urinary catecholamines (CA) and vanillylmandelic acid (VMA) due to lab interference, not increased CA release. Perform diagnostic tests before labetalol therapy to prevent misdiagnosis of pheochromocytoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selective mid-facial neurectomy using intraoperative nerve monitoring system for post-facial paralysis synkinesis.

    JPRAS open·2025
    Same author

    Dynamic CT-perfusion parameters as indicators of microcirculation: investigation in patients without obstructive coronary artery disease.

    Clinical radiology·2024
    Same author

    Antitumor effects of inhibitors of ERK and Akt pathways in canine histiocytic sarcoma cell lines.

    Veterinary journal (London, England : 1997)·2024
    Same author

    Low energy virtual monochromatic CT with deep learning image reconstruction to improve delineation of endoleaks.

    Clinical radiology·2024
    Same author

    Multiple encephalopathy syndrome: a case of a novel radiological subtype of acute encephalopathy in childhood.

    European review for medical and pharmacological sciences·2022
    Same author

    Deep-learning reconstruction to improve image quality of myocardial dynamic CT perfusion: comparison with hybrid iterative reconstruction.

    Clinical radiology·2022

    Area of Science:

    • Clinical Pharmacology
    • Biochemical Diagnostics
    • Endocrinology

    Background:

    • Pheochromocytoma diagnosis relies on elevated urinary catecholamines (CA) and metabolites.
    • Labetalol is used preoperatively for pheochromocytoma management.
    • Potential interferences in diagnostic assays require careful consideration.

    Purpose of the Study:

    • To investigate the effect of oral labetalol on urinary catecholamine and vanillylmandelic acid levels.
    • To determine if labetalol stimulates catecholamine release or interferes with assays.
    • To prevent misdiagnosis of pheochromocytoma in patients receiving labetalol.

    Main Methods:

    • Administered oral labetalol to a preoperative pheochromocytoma patient.
    • Administered oral labetalol to normal volunteers.

    Related Experiment Videos

  • Measured urinary catecholamines (CA) and vanillylmandelic acid (VMA) levels before and after labetalol administration.
  • Analyzed assay results for potential interferences.

    • Main Results:

    • Observed significant increases in urinary CA and VMA post-labetalol in both the patient and volunteers.
    • Demonstrated that labetalol's effect was due to assay interference, not increased CA release.
    • Highlighted the risk of falsely elevated catecholamine metabolite levels.

    Conclusions:

    • Oral labetalol can interfere with urinary catecholamine and vanillylmandelic acid assays.
    • Clinical evaluations for pheochromocytoma should be conducted prior to initiating labetalol therapy.
    • Avoids erroneous diagnosis of pheochromocytoma due to labetalol-induced assay interference.